Alzheimer's disease (AD) is characterized by extensive neurodegeneration and
inflammation in selective brain areas, linked to severely disabling cognitive deficits. Before …

Accumulation of amyloid-β (Aβ) oligomers and phosphorylated Tau aggregates are crucial
pathological events or factors that cause progressive neuronal loss, and cognitive …

Alzheimer's disease (AD) is an extensive age‐associated neurodegenerative disorder. In
spite of wide‐ranging progress in understanding the AD pathology for the past 50 years …

Alzheimer's disease (AD) is a progressive disorder of the brain that gradually decreases
thinking, memory, and language abilities. The aggregation process of amyloid β (Aβ) is a …

Neurological disorders are the biggest concern globally. Out of~ 36 million human
immunodeficiency virus (HIV) positive people, about 30%–60% exhibit neurological …

At present, few available drugs can be used to either improve pathological features or
prevent the progression of Alzheimer's disease (AD). DL0410 ((1, 1′-([1, 1′-biphenyl]-4 …

Alzheimer (AD) is a chronical neurodegenerative disease which is the 6th leading cause of
death worldwide. About 36 million cases in the world and may increase to 115 million in …

阿尔茨海默病(Alzheimer's Disease, AD) 是一种以进行性认知功能障碍和行为损害为特征的
中枢神经系统退行性病变, 其病理特征是A β, tau 蛋白等异常积累, 主要表现为认知功能障碍和 …

Pathological changes in neural network activity play a key role in Alzheimer's Disease but
the underlying processes remain unclear. Key genetic risk factors are correlated with the …

Neurological disorders are the biggest concern globally and ageing contributes in
worsening the disease scenarios. In AD or AD like diseases, there is abnormal accumulation …